news
NICE and Canadian Agency collaborate to offer parallel scientific advice
NICE in the UK and its counterpart - the Canadian Agency for Drugs and Technology in Health have collaborated to offer parallel scientific advice...
List view / Grid view
Manufacturing
news
Microbiological considerations in cleanroom validation
Wickham Laboratories Ltd is delighted to announce our most recent technical article on, “microbiological considerations in cleanroom validation”, which has been featured in European Pharmaceutical Review’s December 2018 issue...
news
Combination antiplatelet therapy reduces risk of recurrent stroke
A combination therapy using the blood thinner cilostazol, along with either aspirin or clopidogrel, was shown to decrease the risk of stroke recurrence...
news
FDA approval for Cablivi to treat rare clotting disorder
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...
news
PDA Italy Chapter has chosen the new COO of PQE Group, Claudio Puglisi, as member of the executive committee for the role of Chapter Liaison and External Relationship
The counting of votes that saw the election of Mr. Claudio Puglisi, new COO of PQE Group, was held last January 31st in Milan, Italy...
news
Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering
Pharmapack Europe has released a ‘European drug delivery and packaging’ report, ahead of the event’s opening which highlights, major challenges and opportunities for the industry in the year ahead...
news
Efforts to advance the development of complex generic drugs
The FDA has issued a statement to promote the development of complex generic drugs to ensure access for patients and healthy drug competition...
news
Late-stage pipeline drugs could compete with only treatment for SMA
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise...
news
Computational method could reduce the risk of drug formulations
A team of researchers have developed a computational method using an algorithm to develop formulations for drugs so they function properly...
news
Public consultation on key principles for ePI of EU medicines
The European Medicine Agency has launched a six month consultation on the principles that will form the basis of the electronic product information (ePI)...
news
Proposed Medicare reforms spark comments about drugs
Reforms that have been proposed by the Centers for Medicare and Medicaid Services have sparked comments from officials and companies alike...
news
Growing role of personalised and precision medicine in cancer treatments
The role of personalised and precision medicine may be ideal for the treatment of cancer, but questions about consequences and society issues still remain...
article
Dr Penny Heaton, Bill & Melinda Gates MRI: ‘Lift while you climb’
As part of EPR’s Women in Pharma series, Dr Penny Heaton, Chief Executive Officer, Bill & Melinda Gates Medical Research Institute, talks to Science Editor Dr Zara Kassam about the need to disrupt global health product development by applying cutting-edge science and technology to combat age-old diseases in the world’s…
news
FDA approval for leukaemia non-chemo combination therapy
The FDA has approved the first ever non-chemotherapy combination treatment using ibrutinib and obinutuzumab for the most common form of adult leukaemia...
news
Tachycardia in cancer patients could signal increased risk of mortality
A study has shown a link between tachycardia and an increased risk of mortality in cancer patients, even up to 10 years after diagnosis...
